CA50785-3A - 0x0000000000006BE6
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
July 12, 2026 - 3:00pm
End Date:
July 20, 2026 - 9:30am
Study Details
Study Number: CA50785
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 6/29/2026 |
| Thursday | 7/2/2026 |
| Monday | 7/6/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 6/29/2026 |
| Thursday | 7/2/2026 |
| Monday | 7/6/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 7/12/2026 3:00:00 PM | Wednesday | 7/15/2026 9:30:00 AM | 1 | Lincoln |
| Return | Monday | 7/20/2026 8:30:00 AM | Monday | 7/20/2026 9:30:00 AM | 1 | Lincoln |
